Overview
Shukra Pharmaceuticals Limited, founded in 1993, specializes in manufacturing and trading pharmaceutical formulations and conducting laboratory testing. Their offerings include a wide range of antibiotics, antifungal, antiviral, sedatives, and more.
The company operates four key manufacturing divisions: tablets, capsules, liquid, and small volume parental, situated in Gujarat.
It collaborates with major pharmaceutical manufacturers like Cadila Healthcare, Intas Pharmaceuticals, and others, aiding in the development of diverse drugs and formulations.
In 2013-14, Shukra Pharmaceuticals underwent a significant restructuring, including the amalgamation of Proper Dealcomm Private Limited and re-organization through a high court-approved scheme.
The company provides a broad spectrum of dosage forms to prestigious pharmaceutical companies worldwide, enhancing its market presence and industry reputation.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
1,385 Cr
- Volatility
Low Risk
- P/E Ratio
50.7
- Industry P/E
32.3
- PEG Ratio
0.4
- P/B Ratio
126.6
- 52W High
65.26
- 52W Low
11.74
Financial Ratios
Sales CAGR
- 1Y
- -56.30%
- 3Y
- 16.73%
- 5Y
- 18.86%
- 10Y
- 23.57%
Profit CAGR
- 1Y
- -48.33%
- 3Y
- 133.65%
- 5Y
- 206.15%
- 10Y
- 62.81%
ROE
- TTM
- —
- 3Y
- 22.31%
- 5Y
- 18.83%
- 10Y
- 13.92%
ROCE
- TTM
- —
- 3Y
- 23.44%
- 5Y
- 18.56%
- 10Y
- 13.48%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
